Vyepti and Excedrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Vyepti and Excedrin together.

The phase IV clinical study analyzes what interactions people who take Vyepti and Excedrin have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Aug, 03, 2022

2 people who take Vyepti and Excedrin together, and have interactions are studied.


What is Vyepti?

Vyepti has active ingredients of eptinezumab-jjmr. eHealthMe is studying from 523 Vyepti users for its effectiveness, alternative drugs and more.

What is Excedrin?

Excedrin has active ingredients of acetaminophen; aspirin; caffeine. It is often used in headache. eHealthMe is studying from 19,324 Excedrin users for its effectiveness, alternative drugs and more.

Number of Vyepti and Excedrin reports submitted per year:

Vyepti and Excedrin drug interactions.

Common Vyepti and Excedrin drug interactions by gender *:

female:

  1. Confusional state
  2. Eye pruritus
  3. Hypersensitivity
  4. Impaired work ability
  5. Nausea
  6. Rhinitis
  7. Vomiting

male:

n/a

Common Vyepti and Excedrin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Eye pruritus
  2. Rhinitis

40-49:

  1. Confusional state
  2. Hypersensitivity
  3. Impaired work ability
  4. Nausea
  5. Vomiting

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Vyepti and Excedrin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Vyepti and Excedrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Excedrin interactions:

Browse all interactions between Excedrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eptinezumab-jjmr and acetaminophen; aspirin; caffeine (the active ingredients of Vyepti and Excedrin, respectively), and Vyepti and Excedrin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: